UK Markets close in 6 hrs 4 mins

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.1900+0.0550 (+1.75%)
At close: 4:00PM EDT

3.3300 +0.14 (4.39%)
Pre-market: 5:18AM EDT

Currency in USD
Earnings estimateCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
No. of analysts7777
Avg. Estimate-0.23-0.23-0.86-0.67
Low estimate-0.34-0.34-1.06-0.9
High estimate-0.13-0.14-0.51-0.32
Year ago EPS-0.25-0.25-1-0.86
Revenue estimateCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
No. of analysts7777
Avg. Estimate3.31M3.46M14.68M21.8M
Low estimate1.76M1.83M7.52M7.99M
High estimate10.7M11.2M48M85.3M
Year ago sales1.49M1.74M6.91M14.68M
Sales growth (year/est)122.00%98.90%112.30%48.50%
Earnings history30/03/202029/06/202029/09/202030/12/2020
Est. EPS-0.31-0.24-0.22-0.22
Actual EPS-0.25-0.25-0.27-0.23
Difference0.06-0.01-0.05-0.01
Surprise %19.40%-4.20%-22.70%-4.50%
EPS trendCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
Current estimate-0.23-0.23-0.86-0.67
7 days ago-0.23-0.23-0.86-0.67
30 days ago-0.23-0.23-0.86-0.67
60 days ago-0.22-0.22-0.88-0.7
90 days ago-0.22-0.22-0.83-0.62
EPS revisionsCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesABUSIndustrySector(s)S&P 500
Current qtr.8.00%N/AN/AN/A
Next qtr.8.00%N/AN/AN/A
Current year14.00%N/AN/AN/A
Next year22.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A